financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Hold Opinion On Adss Of Ing Group
Jul 31, 2025 10:18 PM

12:50 AM EDT, 08/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price to USD25 from USD22, reflecting consensus 2025 P/B of 1.31x. The implied premium to its five-year historical average P/B of 0.84x is justified in our view by ING's improving profitability, reflecting sharp efficiency gains and digital-driven cost discipline. ING delivered resilient H1 2025, with steady net interest and fee income underpinned by strong commercial momentum and diversified revenue streams. While operating expenses have edged higher due to strategic digital infrastructure and sustainable finance advisory investments, provisioning remains conservative and capital adequacy and returns metrics stay robust. Facing potential margin pressure from rate normalization and limited near-term catalysts, management's focus on improving the cost/income ratio through efficiency gains, disciplined capital allocation, and earnings momentum underpin our Hold recommendation. We keep our EPS forecasts of EUR2.00 for 2025 and EUR2.20 for 2026.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Southern Copper Corporation
Oct 31, 2025
11:10 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $55 to $151, driven by an EV/EBITDA multiple of 14.5x applied to our 2027 EBITDA estimate, which is a premium to SCCO's three-year...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Research Alert: CFRA Maintains Sell Opinion On Shares Of Edison International
Oct 31, 2025
11:30 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target remains $48, 7.8x our 2026 EPS estimate (down $0.05 to $6.08; 2025 estimate remains $6.03), a wide discount to peers based on weaker growth expectations vs. peers...
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Research Alert: CFRA Keeps Buy Opinion On Shares Of Edwards Lifesciences Corporation
Oct 31, 2025
11:40 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our 12-month target price to $100 from $93, 35x our 2026 EPS and a slight premium to the company's long-term average forward P/E. We lift our 2025 EPS...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Dexcom, Inc.
Oct 31, 2025
11:35 AM EDT, 10/31/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target to $77 from $89, about 32x our 2026 EPS, below DXCM's average forward P/E and slightly under MedTech peers. We lift our 2025 EPS by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved